GlassScriptPhysician profile
Erin Clayton
NPI 1396403689
$1,143.56
in general payments reported to CMS, 2019-2025
11 companies · $584 in 2025
The $584 reported for 2025 was more than what 76% of Nurse Practitioner providers received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $272 · 2023: $17.88 · 2024: $270 · 2025: $584.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $871.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $871.40 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $454.45 | 2022-2025 | Ozempic, Wegovy, Rybelsus |
| Lilly USA, LLC | $163.49 | 2025 | Zepbound, Mounjaro |
| Dexcom, INC. | $137.91 | 2022-2025 | Dexcom G6 Transmitter |
| Bayer Healthcare Pharmaceuticals INC. | $125.00 | 2022 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $83.54 | 2024-2025 | Jardiance |
| Exact Sciences Corporation | $59.04 | 2024-2025 | Cologuard Collection Kit |
| Abbott Laboratories | $43.55 | 2024 | Freestyle Libre 3 |
| Phathom Pharmaceuticals, INC. | $22.37 | 2024 | Voquezna |
| Pfizer INC. | $20.59 | 2024 | |
| Glaxosmithkline, LLC. | $20.10 | 2025 | Arexvy |
| Janssen Pharmaceuticals, INC | $13.52 | 2024 | Xarelto |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Erin Clayton listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.